- Home
- DTF vs NAUT Comparison
DTF vs NAUT Comparison
Compare DTF & NAUT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DTF
- NAUT
- Stock Information
- Founded
- DTF 1991
- NAUT 2016
- Country
- DTF United States
- NAUT United States
- Employees
- DTF N/A
- NAUT N/A
- Industry
- DTF Investment Managers
- NAUT Biotechnology: Laboratory Analytical Instruments
- Sector
- DTF Finance
- NAUT Industrials
- Exchange
- DTF Nasdaq
- NAUT Nasdaq
- Market Cap
- DTF 79.8M
- NAUT 95.6M
- IPO Year
- DTF N/A
- NAUT N/A
- Fundamental
- Price
- DTF $11.36
- NAUT $0.70
- Analyst Decision
- DTF
- NAUT Strong Sell
- Analyst Count
- DTF 0
- NAUT 1
- Target Price
- DTF N/A
- NAUT $1.75
- AVG Volume (30 Days)
- DTF 21.1K
- NAUT 192.3K
- Earning Date
- DTF 01-01-0001
- NAUT 10-28-2025
- Dividend Yield
- DTF 3.64%
- NAUT N/A
- EPS Growth
- DTF N/A
- NAUT N/A
- EPS
- DTF 0.44
- NAUT N/A
- Revenue
- DTF N/A
- NAUT N/A
- Revenue This Year
- DTF N/A
- NAUT N/A
- Revenue Next Year
- DTF N/A
- NAUT N/A
- P/E Ratio
- DTF $24.34
- NAUT N/A
- Revenue Growth
- DTF N/A
- NAUT N/A
- 52 Week Low
- DTF $10.29
- NAUT $0.62
- 52 Week High
- DTF $11.19
- NAUT $3.09
- Technical
- Relative Strength Index (RSI)
- DTF 60.52
- NAUT 49.90
- Support Level
- DTF $11.21
- NAUT $0.62
- Resistance Level
- DTF $11.38
- NAUT $0.73
- Average True Range (ATR)
- DTF 0.07
- NAUT 0.04
- MACD
- DTF 0.00
- NAUT -0.00
- Stochastic Oscillator
- DTF 83.33
- NAUT 72.32
About DTF DTF Tax-Free Income 2028 Term Fund Inc.
DTF Tax-Free Income 2028 Term Fund Inc is a diversified closed-end management investment company. The Fund's investment objective is current income exempt from regular federal income tax consistent with the preservation of capital. It seeks to achieve its investment objective by investing primarily in a diversified portfolio of investment-grade tax-exempt obligations.
About NAUT Nautilus Biotechnolgy Inc.
Nautilus Biotechnology Inc is a development stage life sciences company creating a platform technology for quantifying and unlocking the complexity of the human proteome. The Company transform the field of proteomics by democratizing access to the proteome and enabling fundamental advancements across human health and medicine. Company's products includes: Proteome Analysis System, Reagent Kits, Software and analysis.